DDD Partners’s ResMed RMD Stock Holding History

DDD Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$211K	Buy	1,081 +20	+2%	+$4.14K	0.01%	155
2026 Q1	$238K	Sell	1,061 -4	-0.4%	-$997	0.02%	125
2025 Q4	$257K	Buy	1,065 +2	+0.2%	+$511	0.02%	114
2025 Q3	$291K	Hold	1,063	–	–	0.02%	105
2025 Q2	$274K	Buy	1,063 +2	+0.2%	+$477	0.03%	100
2025 Q1	$238K	Sell	1,061 -2	-0.2%	-$467	0.03%	93
2024 Q4	$243K	Buy	1,063 +2	+0.2%	+$482	0.03%	89
2024 Q3	$259K	Hold	1,061	–	–	0.03%	92
2024 Q2	$203K	Hold	1,061	–	–	0.02%	92
2024 Q1	$210K	Buy	+1,061	New	+$194K	0.03%	86
2023 Q3	–	Sell	-1,165	Closed	-$255K	–	93
2023 Q2	$255K	Hold	1,165	–	–	0.04%	83
2023 Q1	$255K	Hold	1,165	–	–	0.04%	71
2022 Q4	$242K	Hold	1,165	–	–	0.04%	69
2022 Q3	$254K	Hold	1,165	–	–	0.05%	75
2022 Q2	$244K	Hold	1,165	–	–	0.04%	75
2022 Q1	$283K	Hold	1,165	–	–	0.04%	71
2021 Q4	$303K	Buy	+1,165	New	+$302K	0.04%	77

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

DDD Partners's RMD Position: Q2 2026 in Review

DDD Partners increased its ResMed (RMD) stake by 1.9% in Q2 2026, buying an estimated $4.14K and bringing the position to 1,081 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #155.

DDD Partners first reported a position in RMD in Q4 2021 and has held it in 17 quarters since. The position peaked at $303K in Q4 2021. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

DDD Partners held 1,081 shares of ResMed worth $211K as of Q2 2026.
DDD Partners bought 20 ResMed shares in Q2 2026, an estimated $4.14K.
ResMed made up 0.01% of DDD Partners's portfolio in Q2 2026, its #155 holding.
DDD Partners first reported a position in ResMed in Q4 2021 and has held it in 17 quarters since.
DDD Partners's ResMed position peaked at $303K in Q4 2021.
889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on DDD Partners's 13F filing for Q2 2026, filed 5 Aug 2026.